Comparing survival and treatment response of patients with acquired T790M mutation second‐line osimertinib versus sequential treatment of chemotherapy followed by osimertinib: A real‐world study

Abstract Purpose To investigate the survival benefit with first/second generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs) and osimertinib in different treatment sequences. Methods We retrospectively screened 3807 patients diagnosed with cancer between 2013 and 2019 at...

Full description

Saved in:
Bibliographic Details
Main Authors: Chin‐Chou Wang, Chien‐Hao Lai, Yu‐Ping Chang, Huang‐Chih Chang, Chia‐Cheng Tseng, Kuo‐Tung Huang, Meng‐Chih Lin
Format: article
Language:EN
Published: Wiley 2021
Subjects:
Online Access:https://doaj.org/article/34581f760dc54df492d1a05b4f503c44
Tags: Add Tag
No Tags, Be the first to tag this record!